Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-24-001224
Filing Date
2024-08-23
Accepted
2024-08-23 17:50:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3275
  Complete submission text file 0001972362-24-001224.txt   4701
Mailing Address C/O MAGENTA THERAPEUTICS 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
ZDRAVESKI ZORAN (Reporting) CIK: 0001741285 (see all company filings)

Type: 144

Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Subject) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40603 | Film No.: 241237390
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)